Ysrafil Ysrafil

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Angiotensin Converting Enzyme

Cell Proliferation

Coronavirus Disease

Top Venues

BioImpacts : BI

Asian Pacific journal of cancer prevention : APJCP

Advanced pharmaceutical bulletin

This page only lists publications with an associated author ORCID identifier.

Publications

Sari Eka Pratiwi, Ysrafil Ysrafil, Mardhia Mardhia, Mahyarudin Mahyarudin, Muhammad Inam Ilmiawan, Heru Fajar Trianto, Delima Fajar Liana, Yuri Amia
A novel therapeutic multiepitope vaccine based on oncoprotein E6 and E7 of HPV 16 and 18: An in silico approach. BioImpacts : BI 14 (5) (2024)
Ysrafil Ysrafil, Zulfiayu Sapiun, Indwiani Astuti, Mohammad Anas Anasiru, Nangsih Sulastri Slamet, Hartati Hartati, Fadli Husain, Sukmawati Ahmad Damiti
Designing multi-epitope based peptide vaccine candidates against SARS-CoV-2 using immunoinformatics approach. BioImpacts : BI 12 (4) (2022)
Rachma Greta Perdana Putri, Ysrafil Ysrafil, Wiwara Awisarita
Cancer Incidence in Volcanic Areas: A Systematic Review. Asian Pacific journal of cancer prevention : APJCP 23 (6) (2022)
Ysrafil Ysrafil, Indwiani Astuti
Chitosan nanoparticle-mediated effect of antimiRNA-324-5p on decreasing the ovarian cancer cell proliferation by regulation of GLI1 expression. BioImpacts : BI 12 (3) (2021)
Ysrafil Ysrafil, Indwiani Astuti, Sumadi Lukman Anwar, Ronny Martien, Firasti Agung Nugrahening Sumadi, Tirta Wardhana, Sofia Mubarika Haryana
MicroRNA-155-5p Diminishes in Vitro Ovarian Cancer Cell Viability by Targeting HIF1α Expression. Advanced pharmaceutical bulletin 10 (4) (2020)